The sun was beaming on a hot August afternoon, but Sarah Doherty wasn’t on the beach basking in the final days of summer.

TD Cowen began coverage on Palvella Therapeutics shares, assigning a Buy rating and setting a price target of $44.00. The stock, currently trading at $13.89, has already shown strong momentum with a ...